Showing results (261-270 of 478) with videos related to
Sort By:
Pageof 48
Inflammatory Bowel Diseases|March 6, 2018
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction TherapyParita Patel, Andres Yarur, Sushila Dalal, et al.Gastro Hep Advances|August 12, 2024
Development of a Novel Ulcerative Colitis Endoscopic Mayo Score Prediction Model Using Machine LearningDavid T Rubin, Klaus Gottlieb, Jean-Frederic Colombel, et al.Inflammatory Bowel Diseases|September 26, 2024
Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12Alessandro Armuzzi, David T Rubin, Stefan Schreiber, et al.Inflammatory Bowel Diseases|December 23, 2009
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitisJoel R Pekow, Jeremy T Hetzel, Jami A Rothe, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 4, 2020
Infliximab Does Not Promote the Presence of Collagenolytic Bacteria in a Mouse Model of Colorectal AnastomosisSara Gaines, Sanjiv Hyoju, Ashley J Williamson, et al.Digestive Diseases and Sciences|July 5, 2022
Serum Cytomegalovirus Polymerase Chain Reaction Test Is a Valuable Negative Predictor of Infection in Acute Severe Ulcerative ColitisNathaniel A Cohen, Maryam Zafer, Namrata Setia, et al.Inflammatory Bowel Diseases|January 25, 2024
Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysisMohammad Zamani, Forough Ebrahimtabar, Shaghayegh Alizadeh-Tabari, et al.Inflammatory Bowel Diseases|March 22, 2018
Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and SafetyBritt Christensen, Ruben J Colman, Dejan Micic, et al.Journal of Gastroenterology and Hepatology|May 11, 2021
Predictability of simple endoscopic score for Crohn's disease for postoperative outcomes in Crohn's diseaseShintaro Akiyama, Akihiro Yamada, Jacob E Ollech, et al.Therapeutic Advances in Gastroenterology|July 29, 2026
The efficacy and safety of etrasimod as a first-line advanced therapy for ulcerative colitis: prespecified and post hoc subgroup data from the ELEVATE UC clinical programDavid T Rubin, Charlie W Lees, Filip Baert, et al.Pageof 48